Atosiban
Brand names: TRACTOCILE
Therapeutic Indications
Atosiban is indicated for:
Pre-term birth
Women only, only Adults (18 - 65 years old)
Atosiban is indicated to delay imminent pre-term birth in pregnant women with:
- regular uterine contractions of at least 30 seconds duration at a rate of ≥4 per 30 minutes
- a cervical dilation of 1 to 3 cm (0-3 for nulliparas) and effacement of ≥50%
- age ≥18 years
- a gestational age from 24 until 33 completed weeks
- a normal fetal heart rate.
For this indication, the medical literature mentions below treatments (click for details):
Treatment 1: Intravenous - 6.75-270 mg in 3 doses
Contraindications
Active ingredient Atosiban is contraindicated in the following cases:
Eclampsia, severe pre-eclampsia requiring delivery
No gender/age discrimination
Intrauterine foetal death
No gender/age discrimination
Suspected intrauterine infection
No gender/age discrimination
Abnormal foetal heart rate
No gender/age discrimination
Premature rupture of the membranes >30 weeks of gestation
No gender/age discrimination
Antepartum uterine haemorrhage requiring immediate delivery
No gender/age discrimination
Placenta praevia
No gender/age discrimination
Abruptio placenta
No gender/age discrimination